Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.11 0.0009
mRNA FK866 GDSC1000 pan-cancer AAC 0.1 0.001
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA avicin D CTRPv2 pan-cancer AAC -0.18 0.001
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA clofarabine CTRPv2 pan-cancer AAC 0.095 0.002
mRNA CD-437 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA AICAR GDSC1000 pan-cancer AAC 0.098 0.002
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.11 0.003
Download CSV